home / stock / pddpf / pddpf news


PDDPF News and Press, Medexus Pharmaceuticals Inc From 02/18/20

Stock Information

Company Name: Medexus Pharmaceuticals Inc
Stock Symbol: PDDPF
Market: OTC

Menu

PDDPF PDDPF Quote PDDPF Short PDDPF News PDDPF Articles PDDPF Message Board
Get PDDPF Alerts

News, Short Squeeze, Breakout and More Instantly...

PDDPF - Medexus Pharmaceuticals Reports Revenue of $16.2 Million for the Third Quarter of Fiscal 2020

Q3 2020 Metoject ®  unit market demand increased 88% 1 ; Rupall ™ unit market demand increased 62% 2 ; and Rasuvo ®  unit market demand increased 8% 3 Management to host conference call at 8:00 AM ET on Wednesday, February 19, 2020 TORONT...

PDDPF - Medexus Pharmaceuticals Schedules Third Quarter Fiscal 2020 Conference Call

MONTREAL, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Wednesday, February 19, 2020 to discuss the Compan...

PDDPF - Medexus Pharmaceuticals reports Q2 results

Medexus Pharmaceuticals ( OTCPK:PDDPF ): Q2 net income of C$0.7M More news on: Medexus Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

PDDPF - Medexus Pharmaceuticals Reports Operating and Financial Results for the Second Quarter of Fiscal 2020

Q2 2019 Metoject ™ unit market demand increased 115% 1 ; Rasuvo ™ unit market demand increased 15% 2 ; and Rupall ™ unit market demand increased 66% 3 Medexus management to host conference call at 8:00 AM ET on Monday, December 2, 2019 TORONTO and ...

PDDPF - Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2020 Conference Call

MONTREAL, Nov. 25, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Monday, December 2, 2019 to discuss the Company&#x...

PDDPF - Medexus Granted Priority Review Status for Gliolan® by Health Canada

MONTREAL, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that Health Canada has granted priority review status for the New Drug Submission (NDS) for Gliolan® (5-am...

PDDPF - FOMC, Streaming Wars And JEDI In Focus (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch to s...

PDDPF - Stocks To Watch: FOMC, Streaming Wars And JEDI In Focus

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

PDDPF - Medexus Pharmaceuticals to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference

MONTREAL, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQB: PDDPF) today announced that it will be presenting at the Dawson James Securities 5th Annual Small Cap Growth Conference being hel...

PDDPF - Medexus Announces Changes to Senior Management

MONTREAL, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ”) (TSXV: MDP, OTCQB: PDDPF) today announced changes to the Company’s senior management team. Effective immediately, Mr. Sylvain Chrétien will no longer serve as the Company...

Previous 10 Next 10